Capital World Investors 13D and 13G filings for NovoCure Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 6:14 pm Sale | 2024-02-07 | 13G | NovoCure Limited NVCR | Capital World Investors | 3,276,996 3.100% | -2,557,084 (-43.83%) | Filing |
| 2023-12-11 06:19 am Sale | 2023-12-11 | 13G | NovoCure Limited NVCR | Capital World Investors | 5,834,080 5.500% | -7,065,315 (-54.77%) | Filing |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | NovoCure Limited NVCR | Capital World Investors | 12,899,395 12.300% | 176,181 (+1.38%) | Filing |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | NovoCure Limited NVCR | Capital World Investors | 12,723,214 12.300% | 1,694,783 (+15.37%) | Filing |
| 2021-05-10 12:49 pm Purchase | 2021-05-10 | 13G | NovoCure Limited NVCR | Capital World Investors | 11,028,431 10.700% | 3,272,161 (+42.19%) | Filing |
| 2021-02-16 12:14 pm Purchase | 2021-02-16 | 13G | NovoCure Limited NVCR | Capital World Investors | 7,756,270 7.600% | 7,756,270 (New Position) | Filing |